Nucleic acid chaperone activity of retroviral Gag proteins.
Retrovirus particles in which the Gag protein has not yet been cleaved by the viral protease are termed immature particles. The viral RNA within these particles shows clear evidence of the action of a nucleic acid chaperone (NAC): the genomic RNA is dimeric, and a cellular tRNA molecule is annealed, by its 3' 18 nucleotides, to a complementary stretch in the viral RNA, in preparation for priming reverse transcription in the next round of infection. It seems very likely that the NAC that has catalyzed dimerization and tRNA annealing is the NC domain of the Gag protein itself. However, neither the dimeric linkage nor the tRNA:viral RNA complex has the same structure as those in mature virus particles: thus the conformational effects of Gag within the particles are not equivalent to those of the free NC protein present in mature particles. It is not known whether these dissimilarities reflect intrinsic differences in the NAC activities of Gag and NC, or limitations on Gag imposed by the structure of the immature particle. Analysis of the interactions of recombinant Gag proteins with nucleic acids is complicated by the fact that they result in assembly of virus-like particles. Nevertheless, the available data indicates that the affinity of Gag for nucleic acids can be considerably higher than that of free NC. This enhanced affinity may be due to contributions of the matrix domain, a positively charged region at the N-terminus of Gag; interactions of neighboring Gag molecules with each other may also increase the affinity due to cooperativity of the binding. Recombinant HIV-1 Gag protein clearly exhibits NAC activity. In two well-studied experimental systems, Gag was more efficient than NC, as its NAC effects could be detected at a significantly lower molar ratio of protein to nucleotide than with NC. In one system, binding of nucleic acid by the matrix domain of Gag retarded the Gag-induced annealing of two RNAs; this effect could be ameliorated by the competitive binding of inositol hexakisphosphate to the matrix domain.
HIV Drug Resistance Program, National Cancer Institute-Frederick, Frederick, MD USA.
Alan
A
Rein
D015683:Gene Products, gag / Q000378:metabolism*; D015497:HIV-1 / Q000378:metabolism; D018832:Molecular Chaperones / Q000378:metabolism*; D009696:Nucleic Acids / Q000378:metabolism*; D019590:Nucleocapsid Proteins / Q000378:metabolism; D011485:Protein Binding / Q000502:physiology; D012190:Retroviridae / Q000378:metabolism*
D015683:Gene Products, gag; D018832:Molecular Chaperones; D009696:Nucleic Acids; D019590:Nucleocapsid Proteins